These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24909420)

  • 1. Research/review: Structure and linkage disequilibrium analysis of adamantane resistant mutations in influenza virus m2 proton channel.
    Yu Y; Li X; Hao P; Wang JF; Chou KC
    Curr Drug Metab; 2014; 15(5):526-34. PubMed ID: 24909420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
    Du QS; Huang RB; Wang SQ; Chou KC
    PLoS One; 2010 Feb; 5(2):e9388. PubMed ID: 20186344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus.
    Wang JF; Wei DQ; Chou KC
    Biochem Biophys Res Commun; 2009 Oct; 388(2):413-7. PubMed ID: 19665993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A.
    Kolocouris A; Tzitzoglaki C; Johnson FB; Zell R; Wright AK; Cross TA; Tietjen I; Fedida D; Busath DD
    J Med Chem; 2014 Jun; 57(11):4629-39. PubMed ID: 24793875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of drug inhibition and drug resistance of influenza A M2 channel.
    Pielak RM; Schnell JR; Chou JJ
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7379-84. PubMed ID: 19383794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.
    Bright RA; Shay DK; Shu B; Cox NJ; Klimov AI
    JAMA; 2006 Feb; 295(8):891-4. PubMed ID: 16456087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
    Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
    Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance.
    Thomaston JL; Konstantinidi A; Liu L; Lambrinidis G; Tan J; Caffrey M; Wang J; Degrado WF; Kolocouris A
    Biochemistry; 2020 Feb; 59(4):627-634. PubMed ID: 31894969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.
    Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S
    Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights from studying the mutation-induced allostery in the M2 proton channel by molecular dynamics.
    Wang JF; Chou KC
    Protein Eng Des Sel; 2010 Aug; 23(8):663-6. PubMed ID: 20571121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.
    Duncan MC; Onguéné PA; Kihara I; Nebangwa DN; Naidu ME; Williams DE; Balgi AD; Andrae-Marobela K; Roberge M; Andersen RJ; Niikura M; Ntie-Kang F; Tietjen I
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32599753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-ray Crystal Structure of the Influenza A M2 Proton Channel S31N Mutant in Two Conformational States: An Open and Shut Case.
    Thomaston JL; Wu Y; Polizzi N; Liu L; Wang J; DeGrado WF
    J Am Chem Soc; 2019 Jul; 141(29):11481-11488. PubMed ID: 31184871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and evolution of H1N1 influenza A viruses with adamantanes-resistant mutations worldwide from 1918 to 2019.
    He W; Zhang W; Yan H; Xu H; Xie Y; Wu Q; Wang C; Dong G
    J Med Virol; 2021 Jun; 93(6):3473-3483. PubMed ID: 33200496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural comparison of the wild-type and drug-resistant mutants of the influenza A M2 proton channel by molecular dynamics simulations.
    Gu RX; Liu LA; Wang YH; Xu Q; Wei DQ
    J Phys Chem B; 2013 May; 117(20):6042-51. PubMed ID: 23594107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of adamantane-resistant influenza on a microarray.
    Townsend MB; Smagala JA; Dawson ED; Deyde V; Gubareva L; Klimov AI; Kuchta RD; Rowlen KL
    J Clin Virol; 2008 Jun; 42(2):117-23. PubMed ID: 18299250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adamantane-resistant influenza a viruses in the world (1902-2013): frequency and distribution of M2 gene mutations.
    Dong G; Peng C; Luo J; Wang C; Han L; Wu B; Ji G; He H
    PLoS One; 2015; 10(3):e0119115. PubMed ID: 25768797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza.
    Scott C; Kankanala J; Foster TL; Goldhill DH; Bao P; Simmons K; Pingen M; Bentham M; Atkins E; Loundras E; Elderfield R; Claridge JK; Thompson J; Stilwell PR; Tathineni R; McKimmie CS; Targett-Adams P; Schnell JR; Cook GP; Evans S; Barclay WS; Foster R; Griffin S
    PLoS Pathog; 2020 Aug; 16(8):e1008716. PubMed ID: 32780760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of adamantane-resistant influenza A(H3N2) viruses in Hong Kong between 1997 and 2006.
    Tang JW; Ngai KL; Wong JC; Lam WY; Chan PK
    J Med Virol; 2008 May; 80(5):895-901. PubMed ID: 18360910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.